Andrea Giammarino | Microbiology | Best Researcher Award

Published on by Mechanics Awards

Dr. Andrea Giammarino | Microbiology | Best Researcher Award

Phd Student | La Sapienza University of Rome | Italy

Andrea Giammarino is a rising Italian researcher in microbiology and pharmaceutical sciences, currently pursuing a Ph.D. in “Advances in Infectious Diseases, Microbiology, Legal Medicine and Public Health Sciences” at Sapienza University of Rome. His academic and research interests center on pharmaceutical microbiology, fungal biofilms, virulence modulation, and nanotechnology-based antifungal strategies. in Italy, Giammarino has quickly distinguished himself through his hands-on contributions to antifungal research, particularly involving  species and spp., as well as through his innovative use of Galleria mellonella as a fungal model. He has collaborated extensively with national and international teams, including research conducted at the Universidad Nacional del Nordeste (UNNE) in Argentina under Prof. Gustavo Giusiano’s guidance. Andrea has contributed to various high-impact journals such as  and Microorganisms. He has also presented research at prominent conferences like ISHAM and FIMUA. Alongside his research, he earned his pharmacist habilitation in 2024 and remains committed to improving patient care through scientific innovation. With a solid foundation in both clinical and experimental disciplines, Andrea Giammarino is emerging as a promising scholar contributing to the global effort to combat fungal pathogens and drug resistance through innovative microbial therapeutics.

Professional Profile

Orcid

Education 

Andrea Giammarino’s educational journey reflects a strong foundation in pharmaceutical sciences and specialized training in microbiology. He completed his Master’s Degree in Chemistry and Pharmaceutical Technologies at Sapienza University of Rome (2017–2024), with a thesis focusing on Candida spp and the modulation of their virulence and wall proteins by Carvacrol, underlining his early interest in antifungal therapeutics. In 2024, he successfully passed the Pharmacist Abilitation State Exam, becoming a licensed pharmacist. He also completed a High Formation Course  “The Role of the Pharmacist in Managing Dermatological Patients,” offered by Sapienza University in collaboration with the Ordine dei Farmacisti di Roma. This training enhanced his clinical communication and patient care skills, particularly in dermocosmetics and dermatological therapy. Currently, he is enrolled in the Ph.D. Program (XL cycle) at Sapienza University of Rome, specializing in Microbiology and Parasitology within the broader field of “Advances in Infectious Diseases, Microbiology, Legal Medicine and Public Health Sciences.” Through this rigorous program, he deepens his understanding of microbial pathogenesis, resistance mechanisms, and advanced experimental methods. Andrea’s education is complemented by international research training, including molecular techniques in mycology conducted in Argentina, positioning him for impactful contributions to translational infectious disease research.

Experience

Andrea Giammarino’s professional experience is primarily rooted in academic research, where he explores fungal pathogens, biofilm formation, and antifungal strategies. As a Ph.D. student at Sapienza University of Rome, he actively contributes to microbiology research projects, particularly focusing on fungal virulence modulation, nanoparticle synthesis, and host-pathogen interactions. His scientific work is grounded in experimental microbiology and pharmacology, employing models like Galleria mellonella and techniques such as molecular biology and microscopy. In collaboration with the Instituto de Medicina Regional, Universidad Nacional del Nordeste (UNNE), Argentina, Andrea participated in international research training, gaining expertise in green synthesis of silver nanoparticles and molecular methods for fungal identification and pathogenicity assessment. He worked under the supervision of Prof. Gustavo Giusiano, enhancing his cross-cultural academic and lab experience. Andrea has been a presenter at multiple international and national conferences, including the 22nd ISHAM Congres and FIMUA 2024, where he showcased his research on Candida spp., silver nanoparticles, and HDAC inhibitors. His interdisciplinary work bridges microbiology, pharmacology, and nanotechnology, making him a well-rounded early-career researcher. Andrea also contributed to various collaborative projects within Sapienza University, fostering interdepartmental teamwork and contributing to a robust academic environment in infectious disease research.

Research Focus 

Andrea Giammarino’s research focuses on antifungal resistance, biofilm formation, virulence modulation and nanotechnology-based antimicrobial therapies. A major thrust of his work lies in understanding how natural compounds like  affect fungal pathogens, particularly Candida spp., by altering their wall proteins and virulence factors. This line of inquiry holds promise for developing novel therapeutic agents against drug-resistant fungi. He is also deeply engaged in the synthesis and testing of silver nanoparticles, especially those produced through eco-friendly or biological means. His work with gellan gum-based nanocomposite films incorporating bioreduced silver nanoparticles has demonstrated potential in enhancing antifungal activity, as published in Carbohydrate Polymer Technologies and Applications. Andrea leverages alternative animal models, such as Galleria mellonella, to study the pathogenesis and host response to fungal infections. This model provides ethical and cost-effective means to test antifungal efficacy and host–pathogen interactions.

Awards and Honors

While specific formal awards are not explicitly listed, Andrea Giammarino has earned academic distinction and international recognition through his research presentations, international collaborations, and conference participations. His acceptance into the highly competitive Ph.D. program at Sapienza University’s Department of Public Health and Infectious Diseases reflects recognition of his academic merit and potential. Andrea’s international collaboration with the Universidad Nacional del Nordeste (UNNE) in Argentina, under the mentorship of Professor Gustavo Giusiano, signifies scholarly recognition beyond Italy. His selection to conduct research abroad on green nanoparticle synthesis and molecular fungal methods underscores his reputation for innovation and commitment to global scientific progress.

Publication Top Notes

1. Fungal Biofilm: An Overview of the Latest Nano-Strategies
2. Galleria mellonella as a Model for the Study of Fungal Pathogens: Advantages and Disadvantages
3. Gellan Gum-Based Nanocomposites Films Containing Bio-Reduced Silver Nanoparticles: Synthesis, Characterisation, and Antifungal Activity
4. Identification of Virulence Factors in Isolates of Candida haemulonii, Candida albicans, and Clavispora lusitaniae with Low Susceptibility and Resistance to Fluconazole and Amphotericin.

A F M Motiur Rahman | Bio-chemicals | Best Researcher Award

Published on by Mechanics Awards

Assoc. Prof. Dr A F M Motiur Rahman | liquidos ionicos | Best Researcher Award

Associate Professor at Pharmaceutical Chemistry, Saudi Arabia

A dedicated pharmaceutical scientist, Assoc. Prof. Dr A F M Motiur Rahman holds a Ph.D. from Yeungnam University, South Korea, with a strong foundation in medicinal chemistry, particularly in synthetic molecule design and drug metabolism. Serving as an Associate Professor at King Saud University, Saudi Arabia, he leads research in synthetic molecule development for anticancer applications, mentoring students across various academic levels. His work encompasses innovative synthesis and bio-conjugate chemistry, advancing cancer drug discovery through ongoing projects and published articles.

Publication Profile

scopus

orcid

Education 🏅

Ph.D. in Pharmaceutical Science, Yeungnam University, South Korea, 2007M.Sc. in Organic Chemistry, University of Rajshahi, Bangladesh, 2002B.Sc. in Chemistry (Honors), University of Rajshahi, Bangladesh, 2000H.S.C. in Science, Rajshahi Education Board, Bangladesh, 1995S.S.C. in Science, Rajshahi Education Board, Bangladesh, 1993

Experience 👩‍🏫

Currently an Associate Professor at King Saud University,Assoc. Prof. Dr A F M Motiur Rahman has also served as Assistant Professor, Postdoctoral Research Associate at Kyungpook National University, and Research Professor at Yeungnam University. He’s contributed to Frontiers in Chemistry and the Malaysian Journal of Medical and Biological Research, specializing in heterocyclic chemistry, chromatographic analysis, and organic molecule synthesis.

Awards and Honors 🏆

Recipient of esteemed scholarships including NEDO Fellowship (Japan), BK21 Scholarship (South Korea), and multiple Korea Research Foundation Fellowships, Assoc. Prof. Dr A F M Motiur Rahman  has received numerous recognitions, such as the Yeungnam University Ph.D. Scholarship, reflecting his impactful contributions to pharmaceutical chemistry and organic molecule synthesis.

Research Focus 🔬

Specializing in anticancer agents, Assoc. Prof. Dr A F M Motiur Rahman  leads research in synthesizing bioactive molecules, focusing on enzyme inhibitory activities, topoisomerase inhibition, and bio-conjugate chemistry. His projects emphasize metabolic profiling of synthesized molecules, advancing anticancer drug discovery through the design of synthetic and natural compounds for targeted therapies.

Publication  Top Notes

DNA-binding and Anticancer Research

Title: Exploring the DNA-binding and anticancer potential of polypyridyl ruthenium(II) complexes

Journal: Journal of Molecular Structure, 2025, 1321, Article 140044

Authors: Zhang, D., Li, M., Rahman, A.F.M.M., Liu, Z., Lu, Y.

Citations: 0

Multitarget Anticancer Agents

Title: Synthesis and Evaluation of Thiazolyl-indole-2-carboxamide Derivatives as Potent Multitarget Anticancer Agents

Journal: ACS Omega, 2024, 9(40), Pages 41944–41967

Authors: Saadan, N.M., Ahmed, W.U., Kadi, A.A., Al-Wabli, R.I., Rahman, A.F.M.M.

Citations: 0

Dual Inhibition in Cancer Therapy

Title: Design, synthesis, and mechanistic evaluation of novel benzimidazole-hydrazone compounds as dual inhibitors of EGFR and HER2

Journal: Journal of Molecular Structure, 2024, 1309, Article 138177

Authors: Mirgany, T.O., Rahman, A.F.M.M., Alanazi, M.M.

Citations: 1

Antibacterial Compound Discovery

Title: New antibacterial penicimenolide G with unusual 12-membered resorcylic acid lactone ring isolated from Aspergillus giganteus

Journal: Phytochemistry Letters, 2024, 62, Pages 18–23

Authors: Shamim, A.H.M., Mondol, M.A.M., Hossain, M., Alharbi, H.A., Rahman, A.F.M.M.

Citations: 0

Multi-Kinase Inhibitors Development

Title: Discovery of 1H-benzo[d]imidazole-(halogenated)benzylidenebenzohydrazide Hybrids as Potential Multi-Kinase Inhibitors

Journal: Pharmaceuticals, 2024, 17(7), Article 839

Authors: Mirgany, T.O., Asiri, H.H., Rahman, A.F.M.M., Alanazi, M.M.

Citations: 0

Anticancer Photophysical Studies

Title: Synthesis, Cytotoxicity, and Photophysical Investigations of 2-Amino-4,6-diphenylnicotinonitriles

Journal: Molecules, 2024, 29(8), Article 1808

Authors: Al-Ghamdi, A.R., Rahman, S., Al-Wabli, R.I., Al-Mutairi, M.S., Rahman, A.F.M.M.

Citations: 0

Solar Cell Efficiency

Title: The photon-electrical conversion efficiency of dye-sensitive solar cells fabricated using silver-nanoparticle/titania photocathode

Journal: Applied Research, 2024, 3(1), Article e202300044

Authors: Daniel, L.S., Kaffer, R.T., Kalipi, L.M., Kalengay, M., Uahengo, V.

Citations: 0

Nano Drug Delivery System for Brain

Title: Phospholipid-based nano drug delivery system of curcumin using MSP1D1 protein and poloxamer 407

Journal: Journal of Nanoparticle Research, 2024, 26(1), Article 12

Authors: Shariare, M.H., Mannan, M., Khan, F., Uddin, M.N., Kazi, M.

Citations: 2

Pyrrolo[2,3-d]pyrimidine Kinase Inhibitors

Title: Discovery of New Pyrrolo[2,3-d]pyrimidine Derivatives as Potential Multi-Targeted Kinase Inhibitors and Apoptosis Inducers

Journal: Pharmaceuticals, 2023, 16(9), Article 1324

Authors: Alotaibi, A.A., Alanazi, M.M., Rahman, A.F.M.M.

Citations: 4

Selective Kinase Inhibition

Title: Novel pyrrolo[2,3-d]pyrimidine derivatives as multi-kinase inhibitors with VEGFR-2 selectivity

Journal: Journal of Saudi Chemical Society, 2023, 27(5), Article 101712

Authors: Alotaibi, A.A., Asiri, H.H., Rahman, A.F.M.M., Alanazi, M.M.

Citations: 10

Conclusion

Given the candidate’s robust academic qualifications, international research experience, successful mentorship, and strong track record in pharmaceutical and organic chemistry research, they are exceptionally suited for the Best Researcher Award. Their commitment to teaching, funding acquisition, and contributions to therapeutic compound development mark them as a distinguished researcher who has made impactful contributions to the field. Further engagement in publishing and interdisciplinary initiatives could enhance their already strong candidacy, positioning them as a future leader in pharmaceutical chemistry and organic synthesis.

Dr. Kim Robinson | molecular biology Award | Best Researcher Award

Published on by Mechanics Awards

Dr. Kim Robinson | molecular biology Award | Best Researcher Award

Dr. Kim Robinson, University of York, United Kingdom

Dr. Kim Robinson is academic and researcher in the field of renewable energy, holds a PhD in Bio systems Engineering from Kangwon National University, South Korea. His academic journey has been marked by a profound dedication to advancing solar energy technologies, specifically in solar thermal harvesting and its integration into agricultural and architectural applications.

 

Professional Profiles:

Google scholar

📚 Academic Qualifications

PhD, University of Dundee, UK (2010-2014), title: “Understanding the molecular basis for squamous cell carcinoma” supervised by Prof Andrew South and Prof Irene LeighMSc, University of Dundee, UK (2008-2010) (part-time), “investigating light activated drugs for cancer therapeutics” supervised by Dr Julie Woods and Prof James FergusonBSc (Hons), University of Dundee, UK (2004-2008), FYP “Obtaining an action spectrum for Carprofen induced photosensitivity” supervised by Dr Julie Woods and Prof James Ferguson

🔬 Post-Doctoral Positions Held

Senior Research Fellow, Singapore Research Institute Singapore & ASTAR Skin Research Laboratories, ASTAR, Singapore, (November 2017- August 2023)

🔖 List of Patents

Co-inventor on technology patent (International Publication No. WO 2021/188052 A1, Mar 2021)Co-inventor on technology patent (Provisional Conversion, SG Patent Application No. 10202101805W, 23 February 2021)

📊 Citation Metrics (Google Scholar):

Citations by: All – 2198, Since 2018 –1626

h-index: All – 18, Since 2018 – 16

i10 index: All – 19, Since 2018 –17

📖 Publications  Top Note :

paper publication in
paper publication in
paper publication in
paper publication in